Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
4 Visualizzazioni
• 07/30/23
0
0
Incorporare
administrator
Iscritti
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti